Medium materiality6/10
Myriad Genetics price target lowered to $3 from $5 at Stephens
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Stephens lowers MYGN price target to $3; current price $3.05.
- Stephens lowers MYGN PT to 3; price 3.05.
Key facts
- 01
Target: $3
- 02
Posted price: $3.05
- 03
Analyst firm: Stephens
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.